Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

32.00

+1.60 (5.26%)

At close: Jun 26, 2026, 4:00 PM EDT

32.10

+0.10 (0.31%)

After-hours: Jun 26, 2026, 6:52 PM EDT

Stoke Therapeutics Employees

Stoke Therapeutics had 170 employees as of December 31, 2025. The number of employees increased by 42 or 32.81% compared to the previous year.

Employees

170

Change (1Y)

Growth (1Y)

32.81%

Revenue / Employee

$188,706

Profits / Employee

-$998,629

Market Cap

1.99B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	170	42	32.81%
Dec 31, 2024	128	18	16.36%
Dec 31, 2023	110	-7	-5.98%
Dec 31, 2022	117	15	14.71%
Dec 31, 2021	102	23	29.11%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Company Name	Employees
Iovance Biotherapeutics	975
Lakefront Biotherapeutics NV	558
Viridian Therapeutics	252
Monte Rosa Therapeutics	187
Precigen	160
Tyra Biosciences	87
Rapport Therapeutics	84
Mesoblast	81